QIAGEN NV Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels for Enhanced Genomic Research
QIAGEN NV has announced the launch of its new QIAseq xHYB Long Read Panels, enhancing its next-generation sequencing $(NGS)$ portfolio. This expansion aims to provide target enrichment solutions that facilitate long-read sequencing of complex genomic regions. The new panels are optimized for native long-read platforms, such as PacBio, and are designed to improve the detection of genomic variations like HLA typing, repeat expansions, and structural variants. This development underscores QIAGEN's commitment to offering comprehensive NGS solutions, catering to both short- and long-read sequencing needs, and empowering researchers in fields ranging from immune profiling to cancer biology.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722620965) on July 22, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。